Microbot Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBOT and other ETFs, options, and stocks.

About MBOT

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. 

CEO
Harel Gadot
CEOHarel Gadot
Employees
21
Employees21
Headquarters
Hingham, Massachusetts
HeadquartersHingham, Massachusetts
Founded
1988
Founded1988
Employees
21
Employees21

MBOT Key Statistics

Market cap
134.99M
Market cap134.99M
Price-Earnings ratio
-4.59
Price-Earnings ratio-4.59
Dividend yield
Dividend yield
Average volume
960.41K
Average volume960.41K
High today
$2.10
High today$2.10
Low today
$1.96
Low today$1.96
Open price
$2.10
Open price$2.10
Volume
2.31M
Volume2.31M
52 Week high
$4.67
52 Week high$4.67
52 Week low
$1.25
52 Week low$1.25

Stock Snapshot

With a market cap of 134.99M, Microbot Medical(MBOT) trades at $2.03. The stock has a price-to-earnings ratio of -4.59.

On 2026-01-21, Microbot Medical(MBOT) stock traded between a low of $1.96 and a high of $2.10. Shares are currently priced at $2.03, which is +3.6% above the low and -3.3% below the high.

Microbot Medical(MBOT) shares are trading with a volume of 2.31M, against a daily average of 960.41K.

During the past year, Microbot Medical(MBOT) stock moved between $1.25 at its lowest and $4.67 at its peak.

During the past year, Microbot Medical(MBOT) stock moved between $1.25 at its lowest and $4.67 at its peak.

People also own

Based on the portfolios of people who own MBOT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.